December 23, 2009 โ The Cleveland Clinic this week initiated a phase II trial examining a new oral therapy for ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
December 22, 2009 โ A drug manufacturer recently filed paperwork with the FDA to produce a generic version of the ...
December 21, 2009 โ Revised guidelines on the use of beta-blockers for noncardiac surgery say therapy should ...
December 17, 2009 โ The University of Virginia (UVa) in Charlottesville and AstraZeneca this week entered into a ...
December 16, 2009 โ The FDA's Endocrinologic and Metabolic Drugs Advisory Committee yesterday agreed AstraZeneca ...
December 15, 2009 - The European Medicines Agency (EMEA) recently approved a new indication for Procoralan ...
December 14, 2009 โ A new drug application (NDA) was recently submitted to the U.S. Food and Drug Administration ...
December, 14, 2009 โ A supplemental new drug application (sNDA) has been submitted to the U.S. Food and Drug ...
December 14, 2009 โ First new anti-arrhythmic drug to be approved in the European Union in the last 10 years was ...
December 10, 2009 โ European approval was recently granted for the use of Angiox (bivalirudin) as an anti ...
November 18, 2009 โ Results of preclinical studies with CXL-1020 demonstrate beneficial effects across the board ...
November 21, 2009 โ A drug used to treat erectile dysfunction may improve heart function in children and young ...
November 21, 2009 โ The Food and Drug Administration (FDA) recently announced that it is reviewing data from a ...
November 23, 2009 โ The U.S. Food and Drug Administration (FDA) Nov. 20 approved Revatio (sildenafil) Injection ...
November 18, 2009 โ A new, reversible blood thinner did not prove superior over placebo for its primary endpoints ...
December 23, 2009